Research & Development



  黎舟笑道︰“不是,是對方請我。”他眼角余光瞧見陸老大的人跟著進了小商店,正在一邊做出一副認真挑選水果的樣子,看樣子一時半會不會走。   陸老大驚訝道︰“那你今天早上,你不是要走啊?”热热撸影音先锋   一頓飯吃下來,黎舟都是帶著小心的。日夜撸影音先锋   黎江看到他胳膊上、臉上都是血的樣子,喊了聲“哥”一下就哭了。黎舟又驚又怕,他一只手的手肘處被砸傷,彎曲變形,只能跪在地上用另一只手去摸他的腿,手指都在顫抖了︰“腿有沒有,有沒有受傷……”   五分鐘很快就到,黎舟正準備起身去買票的時候,就听見外面入口那有人跑過來,對方顯然也在找人,瞧見他的時候腳步更快了︰“他在那!”色播影音先锋   黎舟吃了一些,喝了兩瓶水。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo